Retina Health Market Forecast till 2030

Retina Health Market Forecast till 2030

Market Overview

During the forecast period, the retina health market is anticipated to grow at a CAGR of 7.01%. The term ""retina"" refers to the thin layer located at the back of the eye that transforms light entering the eye into electrical signals that the brain may process into images. The prevention of vision problems and even blindness depends on a healthy retina. The increasing frequency of retinal disorders worldwide and the increase in strategic initiatives are credited with driving the growth of the global market for retinal health. In addition, more public and private groups are taking action to raise awareness of retinal illnesses. However, it is projected that the dearth of knowledge about retinal illnesses may impede market expansion.

The global retina health market is expected to witness a substantial market expansion due to the increasing incidences of retinal illnesses like retinitis pigmentosa, diabetic retinopathy, Age-Related Macular Degeneration (AMD), and retinal detachment. Additionally, the market has grown because of the rising prevalence of myopia and cases of vision impairment, particularly during the COVID-19 epidemic. This is because more people are using screens and participating in virtual meetings while working from home, which has increased the prevalence of myopia and raised the chance of developing other progressive eye diseases including AMD. Additionally, growing consumer knowledge of retinal biologics fuels market expansion.

Market Segmentation

Based on the treatment and disease indication, the global market for retinal health has been segmented. The market is divided into categories for medications, therapy, and surgery based on the type of treatment. The global retina health market has been divided into age-related macular degeneration, diabetic retinopathy, inherited retinal illnesses, retinoblastoma, and others based on the indication of the disease.

Regional Analysis

Because of the high prevalence of retinal illnesses and the presence of significant market participants in the region, the North American retina health market is expanding. Due to reasons like the high prevalence of wet AMD, rising diabetes rates, and many elderly individuals, the European retina health market is expanding. Due to the rapidly developing healthcare infrastructure, rising per capita income, rising public awareness of eye health, and the presence of a sizable senior population, the Asia-Pacific (APAC) retina health market is anticipated to register a robust CAGR of 8.33% from 2022 to 2030.

The Middle East, Africa, and Latin America are the remainder of the world. Due to its weak economy, inadequate healthcare infrastructure, lack of qualified experts, and low level of public awareness, the remainder of the globe is predicted to have a slower CAGR than other regions.

Major Players

The key players operating in the global retina health market include Gensight Biologics (France), Novartis AG (Switzerland), Spark Therapeutics, Inc. (Us), Allergan Plc (Subsidiary of AbbVie Inc.) (Ireland), Hemera Biosciences LLC (US), Santen Pharmaceuticals Inc. (Japan), Regenxbio Inc. (US), Oxford Biomedica Plc (UK), Meiragtx Limited (US), Applied Genetic Technologies Corporation (AGTC) (US).

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Companies Mentioned

Gensight Biologics (France)
Novartis AG (Switzerland)
Spark Therapeutics Inc. (Us)
Allergan Plc (Subsidiary of AbbVie Inc.) (Ireland)
Hemera Biosciences LLC (US)
Santen Pharmaceuticals Inc. (Japan)
Regenxbio Inc. (US)
Oxford Biomedica Plc (UK)
Meiragtx Limited (US)
Applied Genetic Technologies Corporation (AGTC) (US)

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.